RIVOS Feasibility (MBO)
← catalyst calendarSponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.
Phase
Not applicable
Status
Withdrawn
Study type
Interventional
Design
Na · None · Device feasibility
Enrollment
0actual
Sites
3
Countries
Belgium, France, India
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Why the sponsor stopped it
Study has been withdrawn per decision of Sponsor.
As filed on the registry record, in the sponsor's own words.
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2025-08-31 | estimated | When the study began enrolling |
| Primary completion | 2026-05-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2026-05-30 | estimated | The whole study's end, after follow-up |
| First posted | 2024-10-31 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2025-09-22 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Malignant Biliary Obstruction
Intervention
- Device: EUS access device
Primary outcomes
what the primary-completion date above is the date OFTechnical Success
measured Day 0 Study Procedure
Safety
measured Day 0 Study Procedure through Day 7 Post-Study Procedure
Device Performance
measured Day 0 Study Procedure
Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed